News & Events
Latest News
September 9, 2021
Apexigen Announces Appointment of Dr.
Frank Hsu as Chief Medical Officer
September 7, 2021
Apexigen to Participate in the H.C. Wainwright 23rd
Annual Global Investment Conference
August 5, 2021
Apexigen Receives Orphan Drug Designation from the FDA for
Sotigalimab (APX005M) for the Treatment of
Soft Tissue Sarcoma
Upcoming Events
September 7, 2021
H.C. Wainwright
23rd Annual Global Investment Conference
Past Events
July 21, 2021
LifeSci Annual Summer Symposium